MassMutual Private Wealth & Trust’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.06K Sell
111
-22
-17% -$1.69K ﹤0.01% 1421
2026
Q2
$11K Hold
133
– – ﹤0.01% 1365
2026
Q1
$10.2K Hold
133
– – ﹤0.01% 1360
2025
Q4
$10.5K Sell
133
-1
-0.7% -$87 ﹤0.01% 1368
2025
Q3
$12.3K Buy
134
+6
+5% +$489 ﹤0.01% 1308
2025
Q2
$8.35K Buy
128
+45
+54% +$2.93K ﹤0.01% 1430
2025
Q1
$5.56K Buy
+83
New +$4.96K ﹤0.01% 1554
2021
Q3
– Sell
-48
Closed -$2K – 1258
2021
Q2
$2K Buy
+48
New +$1.63K ﹤0.01% 989
2018
Q3
– Sell
-23
Closed -$1.54K – 975
2018
Q2
$1.54K Hold
23
– – ﹤0.01% 925
2018
Q1
$1.34K Buy
+23
New +$1.46K ﹤0.01% 897

Other funds holding ANIP

MassMutual Private Wealth & Trust's ANIP Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its ANI Pharmaceuticals (ANIP) stake by 17% in Q3 2026, selling an estimated $1.69K and leaving 111 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1421.

MassMutual Private Wealth & Trust first reported a position in ANIP in Q1 2018 and has held it in 10 quarters since. The position peaked at $12.3K in Q3 2025. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • MassMutual Private Wealth & Trust held 111 shares of ANI Pharmaceuticals worth $8.06K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 22 ANI Pharmaceuticals shares in Q3 2026, an estimated $1.69K.
  • ANI Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1421 holding.
  • MassMutual Private Wealth & Trust first reported a position in ANI Pharmaceuticals in Q1 2018 and has held it in 10 quarters since.
  • MassMutual Private Wealth & Trust's ANI Pharmaceuticals position peaked at $12.3K in Q3 2025.
  • 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.